Too funny, i am actually invested in them due to their fda approved drug iplex.Myotonic muscular distropy, HARS, ALS and ROP are in researched as indications as well.
Expanded access program for ALS patients in italy wiht 200.000 us dollar reimbursement per patient per year with currently 70 patients up from 30 few months back when the program started and a very undervalued market cap by all standards.
Optin agreements with trca and genentech as well. Nice video
Fake blood is still alive (barely) at HemoBiotech (HMBT).
rolandrickperry 2 years ago
2:44 in to the Video: By the Gods the Purification hall has gotten cramped! Must be an even bigger PIA to clean all those pipes.
Used to work at facility pre-Insmed days. Nice to see that Dave is still around. Makes me sorta nostalgic for the old days making fake-blood.
Sindawe 2 years ago
insm is the very strongest buy besides heb
Johneey50 2 years ago
This has been flagged as spam show
Nice Video. Check out TubeViews (dotnet) If you need your video exposed, It has really helped me a bunch. Be blessed!
THIS WORKS! Its amazing.. THANK YOU SO MUCH DUDE!!!!!!
Nusratmiya 3 years ago
Facility is worth more than market value of entire company - talk about undervalued - where's Buffet when you need him?
jlcenda 3 years ago
Too funny, i am actually invested in them due to their fda approved drug iplex.Myotonic muscular distropy, HARS, ALS and ROP are in researched as indications as well.
Expanded access program for ALS patients in italy wiht 200.000 us dollar reimbursement per patient per year with currently 70 patients up from 30 few months back when the program started and a very undervalued market cap by all standards.
Optin agreements with trca and genentech as well. Nice video
crackedt00th 3 years ago 3
FOB is the future!
kvnmcdd 3 years ago 6